ARCHIVES

Crout Resigns As Director Of FDA Drugs Bureau

This article is from The Cancer Letter archive.

Vol. 06 No. 28 | July 11, 1980

Download PDF Visit The Full Archive

Related Articles

Legacy CEO Cheryl Healton says foundation could serve as funder for research on “potentially reduced-exposure products.”

October 29, 2004

Task Force Recommendations Submitted For Control/Centers New Division

August 3, 1979

MicroRNA Biomarkers Linked To Early-Stage Prostate Cancer

February 24, 2012

NIH Dedicates Louis Stokes Laboratories; Royston Retires As Kimmel Center President.

June 22, 2001

Two New Organ Systems Working Groups to Be Considered By NCAB

October 4, 1985

Clinical Trials Approved By NCI Last Month

March 29, 2002